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Summary: Primary care clinicians have a central role in managing influenza/influenza-like 18 
illness (ILI) during influenza pandemics.  This study identifies risk factors for influenza-19 
related complications in children presenting with influenza/ILI in primary care. We 20 
conducted a cohort study using routinely collected linked data from the Clinical Practice 21 
Research Datalink on children aged 17 years and younger who presented with influenza/ILI 22 
during the 2009/10 pandemic.  We calculated odds ratios for potential risk factors in 23 
relation to influenza-related complications, complications requiring intervention, 24 
pneumonia, all-cause hospitalisation, and hospitalisation due to influenza-related 25 
complications within 30 days of presentation.  Analyses were adjusted for potential 26 
confounders including age, vaccination, and socioeconomic deprivation.  Asthma was a risk 27 
factor for influenza-related complications (adjusted odds ratio [OR] 1.48, 95% confidence 28 
interval (CI) 1.21-1.80, P<0.001), complications requiring intervention (adjusted OR 1.44, 29 
95% CI 1.11-1.88; P=0.007), pneumonia (adjusted OR 1.64, 95% CI 1.07-2.51, P=0.024), and 30 
hospitalisation due to influenza-related complications (adjusted OR 2.46, 95% CI 1.09-5.56, 31 
P=0.031).  Neurological conditions were risk factors for all-cause hospitalisation (adjusted 32 
OR 4.25, 95% CI 1.50-12.07, P=0.007) but not influenza-related complications (adjusted OR 33 
1.46, 95% CI 0.83-2.56, P=0.189).  Community-based early interventions to prevent 34 
influenza-related clinical deterioration should therefore be primarily targeted at children 35 
with asthma and neurological conditions. 36 
 37 
 38 
 39 
  40 
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Manuscript 41 
Introduction 42 
Primary care clinicians play a principal role in providing front line care to patients presenting 43 
with influenza-like illness (ILI) during influenza pandemics.[1]   This includes prioritising 44 
influenza vaccination in high risk groups[2, 3] and accurately targeting antibiotics and 45 
antiviral medications to maximise clinical benefit without driving antimicrobial resistance.[4, 46 
5]   47 
 48 
The highest rates of primary care consultations for influenza A-attributable respiratory 49 
disease in the UK are observed in children under 5 years of age, while the highest seasonal 50 
incidence rates for influenza B occur in children aged 5 to 17 years.[6]  Universal childhood 51 
vaccination strategies for seasonal influenza are already being implemented in the US[3] 52 
and UK.[7]   53 
 54 
Preliminary data from England suggest that vaccination of children aged 4 to 11 years may 55 
have a direct impact on reducing illness absenteeism in primary schools.[8]  However, no 56 
significant indirect impact on illness absenteeism in secondary schools has been 57 
demonstrated.[8]  There is also still insufficient evidence on whether universal childhood 58 
vaccination is effective at reducing influenza-related complications and hospitalisations, and 59 
which types of communities are likely to benefit most from this type of approach.[9]   60 
 61 
Targeted strategies which prioritise groups at highest risk of clinical deterioration are 62 
therefore still important in primary care, particularly during influenza pandemics, when 63 
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there is increased demand on health care resources and suitable vaccines may not initially 64 
be available.[10]   65 
A systematic review of studies involving children with seasonal or pandemic influenza/ILI 66 
identified nNeurological conditions, premature birth, sickle cell disease, 67 
immunosuppression, diabetes mellitus and age under two years have been identified as risk 68 
factors for hospitalisation in children with influenza/ILI.[11]  However, these findings are 69 
mainly based on data from studies of seasonal influenza conducted in hospital ambulatory 70 
care settings, and represent risk factors for all-cause hospitalisation rather than influenza-71 
related complications.  Additionally, current definitions of high risk groups do not provide 72 
evidence-based guidance on which risk factors are particularly relevant to paediatric 73 
primary care populations.[2, 3]   74 
 75 
The present study therefore aims to identify risk factors for influenza-related complications 76 
in children presenting in primary care using routinely collected linked data from the Clinical 77 
Practice Research Datalink (CPRD). 78 
 79 
Methods 80 
Source data and population 81 
The Clinical Practice Research Datalink (CPRD) (www.cprd.com) provides anonymised 82 
routinely collected data from patients presenting in UK primary care.[12]   Linkage to 83 
Hospital Episode Statistics (HES), Office for National Statistics mortality data, and Index of 84 
Multiple Deprivation (IMD) scores are available for a subset of CPRD practices in England, 85 
representing about 58% of patients registered at practices contributing to CPRD.  The HES 86 
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database contains details of admissions to NHS hospitals and NHS-funded admissions to 87 
private or charitable hospitals in England.[13] 88 
 89 
We extracted data from the CPRD records of children aged 17 years or younger who 90 
consulted with influenza/ILI during the 2009/10 influenza pandemic (i.e. between 27 April 91 
2009 and 23 May 2010).  We excluded records that did not meet CPRD quality standards[12] 92 
and where data were not available for at least 12 months before the index consultation in 93 
children aged 1 year or older, or at least 30 days before the index consultation in children 94 
younger than 12 months of age.  95 
 96 
Potential risk factors 97 
Potential risk factors were defined as binary variables based on records of pre-specified 98 
Read codes for neurological, haematological, metabolic, cardiac, renal, liver and respiratory 99 
conditions, as well as premature birth and non-haematological malignancies.  Supplement 100 
S1.1 describes these definitions in further detail.  101 
 102 
Outcomes 103 
Our primary outcome was influenza-related complications recorded within 30 days of 104 
presentation with influenza/ILI.  These included respiratory, cardiac, neurological and renal 105 
complications.[14]  Secondary outcomes (all within 30 days of presentation with 106 
influenza/ILI) were pneumonia, influenza-related complications requiring further 107 
intervention (prescription of medication, further investigations or hospitalisation), 108 
hospitalisation or death due to influenza-related complications and all-cause hospitalisation 109 
or death.  At the request of journal reviewers, ‘pneumonia or hospitalisation’ was included 110 
6 
 
Running head: Risk factors for influenza complications 
as an additional secondary outcome.  Supplement S1.2 provides full details of how we 111 
defined and obtained data for these outcomes.   112 
 113 
Potential confounders 114 
Potential confounders considered in this study were: age, sex, socioeconomic deprivation, 115 
vaccination status (2008/9 seasonal influenza, pandemic influenza, pneumococcal conjugate 116 
vaccine and Haemophilus influenzae b), prescription of other medications at the index 117 
presentation with influenza/ILI (e.g. corticosteroids, antibiotics, antivirals), presence of 118 
other potential risk factors, and acute hospitalisations during the 12-month period before 119 
the index presentation.  Socioeconomic deprivation was measured based on Index of 120 
Multiple Deprivation (IMD) score quintiles at Office for National Statistics small area level 121 
(100 houses) using the patient’s postcode.  For children aged less than 12 months at the 122 
index presentation, baseline data on acute hospitalisations between the date of birth and 123 
the date of the index presentation were extracted.  124 
 125 
Data analysis  126 
Baseline data on potential risk factors and confounders were summarised using numbers 127 
and percentages for categorical variables and means and standard deviations for continuous 128 
variables.  To minimise the possibility of unintentional disclosure, categorical variables with 129 
fewer than five patient records were either not reported or combined with related 130 
variables.  Data on duration between the index consultation and influenza-related 131 
complications were summarised as medians and interquartile ranges. 132 
 133 
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Statistical analyses were conducted using Stata version 14.  To examine the association 134 
between potential risk factors and each of our outcomes, we performed logistic regression 135 
to calculate odds ratios with 95% confidence intervals for each potential risk factor, both 136 
unadjusted and adjusted for potential confounders.  Age was modelled as a continuous 137 
fractional polynomial (Stata command mfp).  We created a ‘missing’ category for our 138 
variable on socioeconomic deprivation to use in our main analysis where IMD score data 139 
were not available.  The outcomes all-cause hospitalisation and hospitalisation due to 140 
influenza-related complications were analysed using only CPRD records which were linkable 141 
to Hospital Episode Statistics (HES) data.   142 
 143 
Subgroup analyses were conducted according to three age categories (0-4 years, 5-11 years, 144 
12-17 years).  Pre-specified sensitivity analyses were undertaken in children whose CPRD 145 
records were linked to both IMD score and inpatient HES data, and to examine asthma 146 
requiring treatment with inhaled corticosteroids or other preventer therapies as a potential 147 
risk factor.[15]  148 
 149 
The project was approved by the CPRD Independent Scientific Advisory Committee (protocol 150 
number 15_252R).  The protocol was made available to the journal reviewers. 151 
 152 
Results 153 
Study population 154 
Our study population included 16,779 children who presented with influenza-like illness (ILI) 155 
at CPRD general practices during the 2009/10 influenza pandemic.  Table 1 summarises the 156 
baseline characteristics of these children.  Pandemic influenza vaccination was only 157 
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recorded in 100 children (0.6%) and the 2008/9 seasonal influenza vaccination in 715 158 
children (4.3%).  Antivirals were prescribed at the index consultation in 4037 children 159 
(24.1%) and antibiotics in 985 children (5.9%).   160 
 161 
At least one underlying condition was present in 2575 children (15.4%).  Asthma was the 162 
most prevalent condition (n=2068, 12.3%).  Neurological conditions were coded in 172 163 
children (1.0%) of whom 146 had epilepsy.  Metabolic conditions were found in 125 children 164 
(0.7%) of whom 95 had diabetes mellitus.  Haematological or immunological conditions 165 
were only recorded in 15 children, renal conditions in seven children and non-166 
haematological malignancies in fewer than five children.  No children were recorded as 167 
having cardiac or liver conditions.  168 
 169 
Influenza-related complications were recorded in 1339 of 16,779 children (8.0%).   Median 170 
time to development of an influenza-related complication following the index consultation 171 
was one day (interquartile range 0-8 days).  Forty-six percent of complications (617/1339) 172 
were observed on the same day as the index consultation.  Complications requiring 173 
intervention were observed in 668 children (4.0%) and pneumonia in 207 children (1.2%).  174 
Influenza-related complications were recorded in 695 of 5503 children aged 0 to 4 years 175 
inclusive (13%), accounting for just over half the total number of children who developed 176 
influenza-related complications (695/1339, 52%).   177 
 178 
All-cause hospitalisations occurred in 116 of 9717 children whose CPRD records were linked 179 
to HES data (1.2%). Around half of all-cause hospitalisations (55/116, 47.4%) and 180 
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hospitalisations due to influenza-related complications (32/57, 56.1%) were observed in 181 
children aged 0 to 4 years inclusive.   182 
 183 
Risk factors for influenza-related complications 184 
Table 2 summarises crude and adjusted odds ratios with 95% confidence intervals in relation 185 
to influenza-related complications, complications requiring further intervention, or 186 
pneumonia.  Univariable analyses did not identify any statistically significant risk factors for 187 
these outcomes.  However, after adjustment for baseline covariates and other risk factors, 188 
asthma was found to be a statistically significant risk factor for influenza-related 189 
complications (adjusted odds ratio (OR) 1.48, 95% confidence interval (CI) 1.21-1.80, 190 
P<0.001), complications requiring intervention (adjusted OR 1.44, 95% CI 1.11-1.88, 191 
P=0.007), and pneumonia (adjusted OR 1.64, 95% CI 1.07-2.51, P=0.024).  The association 192 
between neurological conditions and influenza-related complications requiring intervention 193 
was of borderline statistical significance (adjusted OR 1.94, 95% CI 1.01 to 3.75, P=0.047). 194 
 195 
In the multivariable model, prescription of antibiotics or antiviral medications at the index 196 
consultation was associated with significantly reduced likelihood of influenza-related 197 
complications (antibiotics: adjusted OR 0.38, 95% CI 0.26-0.55, P<0.001; antivirals: adjusted 198 
OR 0.33, 95% CI 0.28-0.4, P<0.001).  In contrast, concurrent prescription of both antibiotics 199 
and antivirals together was associated with significantly greater likelihood of influenza-200 
related complications (adjusted OR 4.06, 95% CI 2.02-8.13, p<0.001). Since this interaction 201 
was statistically significant, an interaction term for prescription of antibiotics and antivirals 202 
was also included in the multivariable model. 203 
 204 
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Risk factors for hospitalisation 205 
CPRD records of 9,717 of the 16,779 included children (58%) were eligible for linkage to 206 
Hospital Episode Statistics (HES) data.  All-cause hospitalisations were recorded in 116 207 
children (1.2%).  Following the index consultation, median time to hospital admission was 208 
two days (interquartile range 0 to 16 days).  Thirty-five children were admitted to hospital 209 
on the same day as the index consultation (30.2%).  Nearly half of hospitalisations were 210 
coded as being for influenza-related complications (n=57, 49.1%).  Median time to 211 
hospitalisation for influenza-related complications was one day (interquartile range 0 to 12 212 
days).  Sixteen children were admitted to hospital on the same day as the index consultation 213 
(28.1%).  Pneumonia or hospitalisation was recorded in 224 children (2.3%).  No deaths 214 
were recorded in our study population. 215 
 216 
Table 3 summarises crude and adjusted odds ratios with 95% confidence intervals in relation 217 
to all-cause hospitalisations and hospitalisations due to influenza-related complications.  218 
The presence of neurological conditions was found to be a statistically significant risk factor 219 
for all-cause hospitalisation in both crude and adjusted analyses (crude OR 3.57, 95% CI 220 
1.29-9.89, P=0.014, adjusted OR 4.25, 95% CI 1.49-12.06, P=0.007).  Neurological conditions 221 
were also associated with significantly greater risk of pneumonia or hospitalisation (crude 222 
OR 3.30, 95% CI 1.51-7.19, P=0.003, adjusted OR 3.62, 95% CI 1.62-8.08, P=0.002). 223 
 224 
 225 
Asthma was a statistically significant risk factor for hospitalisation due to influenza-related 226 
complications after adjustment (adjusted OR 2.45, 95% CI 1.08-5.55, P=0.031), but was not a 227 
risk factor for all-cause hospitalisation (crude OR 1.10, 95% CI 0.63-1.93, P=0.740; adjusted 228 
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OR 1.53, 95% CI 0.81-2.86, P=0.188) or for pneumonia or hospitalisation (crude OR 1.01, 229 
95% CI 0.66-1.53, P=0.979, adjusted OR 1.28, 95% CI 0.8-2.05, P=0.300). 230 
 231 
In the multivariable model, prescription of antiviral medications was associated with a 232 
significantly reduced likelihood of both influenza-related hospitalisations (adjusted OR 0.43, 233 
95% CI 0.19-0.94; P=0.036),  and all-cause hospitalisations (adjusted OR 0.60, 95% CI 0.36-234 
0.99; P=0.044) and pneumonia or hospitalisation (adjusted OR 0.3, 95% CI 0.19-0.47, 235 
P<0.001). 236 
 237 
Subgroup and sensitivity analyses 238 
After adjustment for baseline covariates and other risk factors, asthma was a significant risk 239 
factor for pneumonia and hospitalisations due to influenza-related complications in children 240 
aged 4 years and younger (Supplement S2). Asthma was also a significant risk factor for 241 
influenza-related complications in children aged 5-11 years and 12-17 years after 242 
adjustment.  The presence of a neurological condition was a risk factor for all-cause 243 
hospitalisation in children aged 5-11 years. 244 
 245 
Supplement S3 summarises the results of our pre-specified sensitivity analyses on asthma 246 
requiring preventer therapy (S3.1) and CPRD records linked to both IMD score and inpatient 247 
HES data (S3.2). The findings of these analyses were consistent with those of our main 248 
analyses.  We also conducted post hoc sensitivity analysis excluding children in whom 249 
influenza-related complications were recorded on the same day as the index consultation.  250 
The findings of this analysis were broadly consistent with the main analysis.  However, 251 
asthma was no longer a significant risk factor for pneumonia (adjusted OR 0.99, 95% CI 0.3-252 
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3.29, P=0.98).  The association between antibiotic prescriptions and influenza-related 253 
complications was also no longer statistically significant (adjusted OR 0.74, 95% CI 0.51-1.08, 254 
P=0.115).  There were insufficient data to estimate an odds ratio for neurological conditions 255 
in relation to complications requiring intervention.   256 
 257 
Discussion 258 
Principal findings 259 
Our study provides a comprehensive assessment of risk factors for influenza-related 260 
complications and all-cause hospitalisations in children using routinely collected data from a 261 
large UK primary care cohort.  Asthma is a strong risk factor for influenza-related 262 
complications, including pneumonia, in children presenting with influenza/ILI in primary 263 
care.  Children with nNeurological conditions, mainly epilepsy (which is not mentioned in 264 
current risk group definitions), are associated withat increased greater risk of all-cause 265 
hospitalisation, but not influenza-related complications.  At least half of influenza-related 266 
complications and hospitalisations occur within one day of initial presentation in primary 267 
care. 268 
 269 
Comparison with existing literature 270 
The rapid onset of influenza-related complications which we observed in our cohort is 271 
consistent with previous reports that around 80% of intensive care admissions among 272 
children with laboratory-confirmed influenza occur within 24 hours of hospitalisation.[16]  273 
 274 
Previous systematic reviews have identified asthma as a risk factor for pneumonia[17] and 275 
found that neurological conditions are associated with greater risk of all-cause 276 
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hospitalisation.[11, 17]  However, these analyses were based on data from adults and 277 
children[17] and did not adjust for important potential confounders, including 278 
socioeconomic deprivation and vaccination status.[11, 17]   279 
 280 
Neuromuscular and neurocognitive disorders have previously been identified as risk factors 281 
for pneumonia in patients with seasonal influenza.[17]  However, we did not observe a 282 
significant association between neurological conditions and influenza-related complications 283 
or hospitalisations.  This may have been due to health care professionals using different 284 
codes to record complications, or having a lower threshold for admitting these children to 285 
hospital for observation, since clinical prognosis is reported to be worse if complications do 286 
develop.[18]  287 
 288 
We did not find premature birth or diabetes to be significant risk factors in our cohort, 289 
although these have previously been reported as risk factors in children presenting in 290 
hospital ambulatory care settings.[11]  This may reflect differences between these settings 291 
in the complexity and severity of these conditions among children presenting with 292 
influenza/ILI.  Coding of premature birth may also be less reliable in primary care records.  293 
Additionally, we did not have sufficient data to examine whether immunosuppression was a 294 
risk factor in primary care as well as hospital ambulatory care settings[11] due to the limited 295 
number of children with haematological or immunological conditions in our cohort.  This 296 
may reflect recommendations for these children to be referred early or seen directly in 297 
hospital when acutely unwell to facilitate prompt management of suspected neutropenic 298 
sepsis.[19]  299 
 300 
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Our observation that children who were prescribed antibiotics or antivirals were less likely 301 
to develop influenza-related complications should be interpreted with caution, since it was 302 
not possible to adjust for severity of the acute illness episode or other unmeasured 303 
confounders.  The statistically significant interaction we observed between antibiotic and 304 
antiviral prescriptions may suggest some confounding by illness severity.  Lower re-305 
attendances with cough within one month have also been observed in patients with acute 306 
lower respiratory tract infections given immediate or delayed prescriptions for 307 
antibiotics.[20]   308 
 309 
Strengths and limitations 310 
Our study identifies risk factors for influenza-related complications of direct relevance to 311 
children presenting in primary care, where most influenza/ILI episodes are initially assessed.  312 
Linkage to inpatient Hospital Episodes Statistics data and Index of Multiple Deprivation 313 
score data enabled more detailed analyses than have previously been possible on unlinked 314 
routinely collected primary care data from the General Practice Research Database.[14] 315 
 316 
Our methods of identifying relevant consultations using consultation codes for influenza-like 317 
illness are likely to be robust, given that these codes were used more frequently during the 318 
2009/10 pandemic, with the highest peak in consultations observed in children under 15 319 
years of age.[21]  Studying consultations during the 2009/10 pandemic also helped enrich 320 
our sample for patients with influenza and minimise potential confounding due to antiviral 321 
treatment at the index consultation, since during the pandemic, antivirals were 322 
recommended in all patients with influenza/ILI, not just those considered to be at greater 323 
risk of complications.   324 
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 325 
The available data allowed us to identify risk factors for influenza-related complications 326 
managed in the community, and to examine risk factors for hospitalisations due to 327 
influenza-related complications separately from all-cause hospitalisations. We also adjusted 328 
our analyses for a range of potential confounders, including socioeconomic status, 329 
vaccination status, and prescription of medications at the index consultation. 330 
 331 
To increase our focus on risk factors for hospital admissions for clinical deterioration, we 332 
defined hospitalisation outcomes as hospital admissions lasting 24 hours or longer.  333 
Previous studies did not specify the minimum duration of hospital admissions which they 334 
considered as hospitalisation outcome events[11, 17]  and may therefore have included a 335 
considerable proportion of admissions for short periods of observation rather than 336 
treatment of complications.  In our cohort, nearly half of hospitalisations coded in HES were 337 
for less than 24 hours (110/226, 48.7%). 338 
 339 
Our main limitation was the lack of an established linkage between data from the National 340 
Pandemic Flu Service (NPFS) and CPRD.  This linkage would have been highly informative, as 341 
during the 2009/10 influenza pandemic, almost six times as many patients contacted the 342 
NPFS instead of their general practice for advice on influenza/ILI.[22]  Additionally, CPRD 343 
records may not have contained complete data on antiviral medications dispensed during 344 
the 2009/10 pandemic, since general practices did not consistently record allocation of ‘flu 345 
vouchers’, which were required to authorise supply of antivirals from the national stockpile. 346 
 347 
 348 
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We did not have sufficient data to assess haematological or immunological conditions, renal 349 
conditions, non-haematological malignancies, cardiac conditions or liver conditions, which 350 
may also be important risk factors for influenza-related complications in children.  Our 351 
definition of influenza-related complications was based on the definition used in a 352 
previously published analysis of data from the General Practice Research Database.[14]  This 353 
definition was intentionally broad to facilitate inclusion of the wide range of complications 354 
managed in the community, as well as allow for variations in coding practices among 355 
primary care clinicians.  However, we recognise that certain consultation codes may be used 356 
in association with presentations other than influenza/ILI and complications related to this.  357 
Ascertainment of clinical deterioration specifically related to the index influenza/ILI 358 
consultation would require analysis of free text entries.  However, this was not feasible with 359 
the resources available for this study.  360 
 361 
It was not possible to address confounding due to severity of the index influenza/ILI 362 
episode, as data on clinical features relating to illness severity, including vital sign 363 
measurements, indicators of respiratory distress, and duration of illness, are not 364 
consistently coded in CPRD.  We were also unable to adjust our analyses for additional social 365 
determinants such as access to health care and ethnicity due to lack of available data.  366 
Although we had intended to adjust our analyses relating to asthma according to British 367 
Thoracic Society treatment step, we did not conduct this analysis because of difficulties with 368 
defining this variable reliably using the available data.  Nevertheless, we were still able to 369 
conduct our pre-specified subgroup analysis examining asthma requiring treatment with 370 
inhaled corticosteroids or other preventer therapies as a risk factor.   371 
 372 
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Implications for clinical practice and further research 373 
Primary care services should target children with asthma and neurological conditions when 374 
delivering interventions to prevent influenza and influenza-related clinical deterioration.  375 
Although asthma requiring regular preventer therapy is already highlighted as a risk 376 
factor,[2] clinicians should also assess risk in other children with asthma, particularly high 377 
users of short-acting bronchodilators who may have poor disease control and hence also be 378 
at greater risk.[23]  Children with epilepsy should also be highlighted as a risk group.  In our 379 
study, 85% of children with neurological conditions had epilepsy.  However, epilepsy is not 380 
mentioned in current risk group definitions,[2, 3] and is less commonly recognised by 381 
clinicians as a risk factor.[24]   382 
 383 
Nevertheless, most influenza-related complications still occur in children who do not have 384 
known risk factors.[25]  Influenza vaccination is therefore still important in these children.  385 
Based on recommendations from the Joint Committee on Vaccination and Immunisation,[7] 386 
the UK introduced a universal childhood seasonal influenza vaccination programme in 387 
2013/14, starting with children aged 2 and 3 years, and extending up to children aged eight 388 
to nine years (i.e. year 4 of school) since winter 2017/18.[26]  However,  389 
Clinicians who consider intervening with antibiotics or antivirals should be aware that most 390 
complications and clinical deteriorations occur soon after presentation. Early treatment with 391 
antibiotics and antivirals should particularly be considered in children with asthma and 392 
neurological conditions, even if they have been vaccinated.  eEffectiveness of the 2015/16 393 
seasonal influenza vaccination was only around 58% in children aged 2 to 17 years in the 394 
UK.[27]  Furthermore, seasonal influenza vaccination rates in children with ‘at risk’ 395 
conditions have not improved from around 40% since 2013/14.[28] and may be even lower 396 
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during an influenza pandemic due to the time needed to develop and implement a suitable 397 
vaccine.  Primary care clinicians may therefore need to consider more readily available 398 
treatments such as antibiotics and antiviral medications, especially given our observation 399 
that at least half of complications and hospitalisation occur within one day of initial 400 
presentation.     401 
Greater emphasis should particularly be placed on improving vaccination rates in school 402 
aged children[28]  given our findings that asthma and neurological conditions are risk 403 
factors in this age group.   404 
 405 
Strategies to inform efficient use of antibiotics and antivirals may include validated clinical 406 
decision rules and involving use of point-of-care testsing for inflammatory markers such as 407 
C-reactive protein (CRP)[29] and potential respiratory pathogens including influenza.[30]  408 
Further research is needed to inform efficient and cost-effective implementation of such 409 
strategies. 410 
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Table 1: Baseline characteristics of study population (N = 16,779) 508 
Characteristic Number (%) or Mean (SD) 
Age (years) 8.40 (5.09)  
Male  8492 (50.6) 
Underlying conditions*:  
Asthma 2068 (12.3) 
Premature birth 291 (1.7) 
Neurological 172 (1.0) 
Metabolic 125 (0.7) 
Haematological conditions/immunosuppression 15 (0.1) 
Renal 7 (0.04) 
Socioeconomic deprivation (IMD quintile)**: 
1. (Least deprived) 2125 (12.7) 
2. 1844 (11.0) 
3. 1729 (10.3) 
4. 2012 (12.0) 
5. (Most deprived) 2002 (11.9) 
Not linked to IMD 7067 (42.1) 
Vaccination status: 
2008/9 seasonal influenza vaccine 715 (4.3) 
Pandemic influenza vaccine 100 (0.6) 
Pneumococcal conjugate vaccine 5432 (32.4) 
Haemophilus influenzae b vaccine 15,470 (92.2) 
Prescriptions at index consultation: 
Antibiotic 985 (5.87) 
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Antiviral 4037 (24.1) 
Inhaled bronchodilator 112 (0.7) 
Inhaled corticosteroid 184 (1.1) 
One or more acute hospitalisations in previous 
year  
214 (1.28) 
SD = Standard Deviation; IMD = Index of Multiple Deprivation 
*One or more underlying conditions recorded in 2575 children. 
** IMD quintiles based on IMD scores according to patient’s postcode at Office for 
National Statistics small area level (100 houses).  Linked IMD score data available for 
9712 children. 
509 
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Table 2: Crude and adjusted odds ratios with 95% confidence intervals in relation to influenza-related complications (N = 16,779) 
Underlying 
condition 
n (%) 
Influenza-related complications (1,339 
events) 
Influenza-related complications 
requiring intervention (668 events) 
Pneumonia (207 events) 
N (%)  
Odds ratio (95% CI; p) 
N (%)  
Odds ratio (95% CI; p) 
N (%)  
Odds ratio (95% CI; p) 
Crude Adjusted* Crude Adjusted* 
Crude Adjusted* 
Asthma 
2068 
(12.3) 
152 
(7.4) 
0.90 (0.76-
1.08; 0.259) 
1.48 (1.21-
1.8; <0.001) 
82 
(4.0) 
1.00 (0.79-1.26; 
0.968) 
1.44 (1.11-
1.88; 0.007) 
29 
(1.4) 
1.16 (0.78-1.72; 
0.459) 
1.64 (1.07-
2.51; 0.024) 
Premature 
birth 
291 (1.7) 
28 (9.6) 
1.23 (0.83-
1.83; 0.298) 
1.23 (0.82-
1.84; 0.312) 
13 
(4.5) 
1.13 (0.65-1.98; 
0.669) 
1.09 (0.62-
1.93; 0.76) 
<5 
0.83 (0.26-2.62; 
0.752) 
0.86 (0.27-
2.73; 0.799) 
Neurological 172 (1.0) 
14 (8.1) 
1.02 (0.59-
1.77; 0.938) 
1.46 (0.83-
2.56; 0.189) 
10 
(5.8) 
1.5 (0.79-2.85; 
0.220) 
1.94 (1.01-
3.75; 0.047) 
<5 
1.43 (0.45-4.51; 
0.544) 
1.67 (0.52-
5.36; 0.390) 
Metabolic 125 (0.7) 
8 (6.4) 
0.79 (0.38-
1.62; 0.514) 
1.24 (0.59-
2.58; 0.571) 
6 (4.8) 
1.22 (0.53-2.78; 
0.639) 
1.74 (0.75-
4.04; 0.196) 
<5 
1.31 (0.32-5.31; 
0.710) 
2.03 (0.49-
8.46; 0.332) 
CI = confidence interval, n = number of children, N = number of children with outcome event.  *Adjusted for age, sex, socioeconomic deprivation, 
vaccination status (2008/9 seasonal influenza vaccine, pandemic influenza vaccine, pneumococcal conjugate vaccine and Haemophilus influenzae b), 
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prescription of medications at index consultation (antivirals, antibiotics, antivirals*antibiotics, inhaled bronchodilators, inhaled corticosteroids), presence 
of other underlying conditions and acute hospitalisation in the previous year.   
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Table 3: Crude and adjusted odds ratios with 95% confidence intervals in relation to hospitalisation (n = 9,717) 
Underlying 
condition 
n (%) 
All-cause hospitalisation (116 events) Hospitalisation due to influenza-related complication (57 
events) 
N (%)  Odds ratio (95% CI; p) 
N (%)  
Odds ratio (95% CI; p) 
Crude Adjusted Crude Adjusted 
Asthma 
1079 
(11.1) 
14 (1.3) 1.10 (0.63-1.93; 
p=0.740) 
1.53 (0.81-2.86; 0.187) 8 (0.7) 1.31 (0.62-2.77; 0.481) 2.46 (1.09-5.56; 0.031) 
Premature 
birth 
181 (1.9) <5 1.41 (0.44-4.47; 
p=0.564) 
1.22 (0.38-3.95; 0.739) 0 (0) NC NC 
Neurological 
99 (1) <5 
3.57 (1.29-9.89; 0.014) 4.25 (1.5-12.07; 0.007) 0 (0) NC NC 
Metabolic 
71 (0.7) <5 
2.42 (0.59-10.01; 0.221) 2.88 (0.67-12.36; 0.155) <5 2.45 (0.33-17.92; 0.379) 3.88 (0.5-29.93; 0.194) 
CI = confidence interval, n = number of children, N = number of children with outcome event, NC = not calculable 
*Adjusted for age, sex, socioeconomic deprivation, vaccination status (2008/9 seasonal influenza vaccine, pandemic influenza vaccine, pneumococcal 
conjugate vaccine and Haemophilus influenzae b), prescription of medications at index consultation (antivirals, antibiotics, antivirals*antibiotics, inhaled 
bronchodilators, inhaled corticosteroids), presence of other underlying conditions and acute hospitalisation in the previous year.   
 
